300830.SZ(300830.SZ)
300830.SZ
| FY | 2015 | 2016 | 2017 | 2019 | 2020 | 2021 | 2022 | 2024 |
|---|---|---|---|---|---|---|---|---|
| High | — | — | — | — | 19.91 | 16.07 | 14.56 | 9.22 |
| Low | — | — | — | — | 6.34 | 8.21 | 6.52 | 4.30 |
| Adj EPS | 0.65 | 0.65 | 0.45 | 0.25 | 0.21 | 0.15 | 0.10 | 0.08 |
| Chg/Yr | — | -1% | -31% | -45% | -13% | -29% | -34% | -20% |
| Div | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.05 | 0.02 |
Fair value (7.0x) multiplies each year's earnings per share by a growth-based multiple: steady growers (5–15% a year) get 15x, faster growers get their growth rate as the multiple (capped at 30x), and slower growers step down below 15x. 300830.SZ has grown earnings about -26.9% a year, so the line uses 7.0x.
Earnings are adjusted figures on the same basis analysts forecast, built from reported quarters; years beyond the last completed fiscal year use the analyst consensus (dashed). The verdict calls a stock over- or undervalued only when the price sits more than 10% from the fair value line.